200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 79763-32-9

79763-32-9

79763-32-9 | 9H-Purine-9-ethanol, 6-amino-beta-hexyl-alpha-methyl-, (R*,S*)-(+-)-

CAS No: 79763-32-9 Catalog No: AG005HE1 MDL No:

Product Description

Catalog Number:
AG005HE1
Chemical Name:
9H-Purine-9-ethanol, 6-amino-beta-hexyl-alpha-methyl-, (R*,S*)-(+-)-
CAS Number:
79763-32-9
Molecular Formula:
C14H23N5O
Molecular Weight:
277.3653
IUPAC Name:
(2R,3S)-3-(6-aminopurin-9-yl)nonan-2-ol
InChI:
InChI=1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11+/m1/s1
InChI Key:
IOSAAWHGJUZBOG-MNOVXSKESA-N
SMILES:
CCCCCC[C@H](n1cnc2c1ncnc2N)[C@H](O)C

Properties

Complexity:
291  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
277.19g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
277.372g/mol
Monoisotopic Mass:
277.19g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
89.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.6  

Literature

Title Journal
Reduced adenosine release from the aged mammalian heart. Journal of cellular physiology 20121101
Measurement of deoxyinosine adduct: Can it be a reliable tool to assess oxidative or nitrosative DNA damage? Toxicology letters 20121017
Adenosine-mediated cardiovascular toxicity in amitriptyline-poisoned rats. Drug and chemical toxicology 20121001
On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic crossclamping entraps intracellular adenosine and protects against reperfusion injury: role of adenosine A1 receptor. The Journal of thoracic and cardiovascular surgery 20120701
The adenosine deaminases of Plasmodium vivax and Plasmodium falciparum exhibit surprising differences in ligand specificity. Journal of molecular graphics & modelling 20120501
Distinctive immunoregulatory effects of adenosine on T cells of older humans. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20120301
Dynein dysfunction disrupts intracellular vesicle trafficking bidirectionally and perturbs synaptic vesicle docking via endocytic disturbances a potential mechanism underlying age-dependent impairment of cognitive function. The American journal of pathology 20120201
Adenosine activation of A(2B) receptor(s) is essential for stimulated epithelial ciliary motility and clearance. American journal of physiology. Lung cellular and molecular physiology 20110801
Inhibition of ATP release from erythrocytes: a role for EPACs and PKC. Microcirculation (New York, N.Y. : 1994) 20110201
Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells. The Biochemical journal 20101215
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors. The Journal of pharmacology and experimental therapeutics 20101101
Rapid determination of adenosine deaminase kinetics using fast-scan cyclic voltammetry. Physical chemistry chemical physics : PCCP 20100914
Mechanisms regulating the nuclear translocation of p38 MAP kinase. Journal of cellular biochemistry 20100815
Strategy to fabricate an electrochemical aptasensor: application to the assay of adenosine deaminase activity. Analytical chemistry 20100415
A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance. Epilepsia 20100301
The effects of dynein inhibition on the autophagic pathway in glioma cells. Neuropathology : official journal of the Japanese Society of Neuropathology 20100201
Caspase-4 activation in association with decreased adenosine deaminase activity may be a factor for gastric ulcer. Digestion 20100101
Influence of an adenosine deaminase inhibitor, erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride, on 5-HT2CR mRNA editing in primary cultured cortical cells. Biological & pharmaceutical bulletin 20100101
Purinergic modulation in the development of the rat uncrossed retinotectal pathway. Neuroscience 20091110
Dynein motor contributes to stress granule dynamics in primary neurons. Neuroscience 20090317
Adenosine as an endogenous regulating factor of hippocampal sharp waves. Hippocampus 20090201
Shared requirement for dynein function and intact microtubule cytoskeleton for normal surface expression of cardiac potassium channels. American journal of physiology. Heart and circulatory physiology 20090101
Kinetic characterization of adenosine deaminase activity in zebrafish (Danio rerio) brain. Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 20080901
Conformational change of adenosine deaminase during ligand-exchange in a crystal. Biochemical and biophysical research communications 20080815
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. Journal of medicinal chemistry 20080724
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nature chemical biology 20080501
[Conformation of adenosine deaminase in complexes with inhibitors: application of selective quenching of fluorescence emission]. Biofizika 20080101
The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation. Critical care (London, England) 20080101
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. The Journal of pharmacology and experimental therapeutics 20070801
Methotrexate and erythro-9-(2-hydroxynon-3-yl) adenine therapy for rat adjuvant arthritis and the effect of methotrexate on in vivo purine metabolism. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20070601
Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine. Experimental physiology 20070101
Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid. Pharmacology 20070101
Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity. Journal of applied toxicology : JAT 20070101
Fine-tuning modulation of myenteric motoneurons by endogenous adenosine: on the role of secreted adenosine deaminase. Autonomic neuroscience : basic & clinical 20060630
Solid-phase enzyme activity assay utilizing an entrapped fluorescence-signaling DNA aptamer. Angewandte Chemie (International ed. in English) 20060512
The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line. Osteoarthritis and cartilage 20060501
Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Circulation 20060501
Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free radical biology & medicine 20060315
Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circulation research 20060203
Assay of adenosine deaminase isoforms by HPLC. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202
A new chemical tool for exploring the physiological function of the PDE2 isozyme. Bioorganic & medicinal chemistry letters 20060115
Extracellular inosine participates in tumor necrosis factor-alpha induced nitric oxide production in cultured Sertoli cells. Molecular and cellular biochemistry 20060101
Adenosine down-regulates giant depolarizing potentials in the developing rat hippocampus by exerting a negative control on glutamatergic inputs. Journal of neurophysiology 20051001
Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway. Cell proliferation 20051001
Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure. American journal of physiology. Heart and circulatory physiology 20050901
Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nature genetics 20050701
Effects of various selective phosphodiesterase inhibitors on carbachol-induced contraction and cyclic nucleotide contents in the guinea pig gall bladder. The Journal of veterinary medical science 20050701
Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system. Biochemistry 20050614
Adenosine-dependent induction of glutathione peroxidase 1 in human primary endothelial cells and protection against oxidative stress. Circulation research 20050429
The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium. European journal of pharmacology 20050411
Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes. Experimental biology and medicine (Maywood, N.J.) 20050401
Protective effect of adenosine and purine nucleos(t)ides against the death by hydrogen peroxide and glucose deprivation in rat primary astrocytes. Neuroscience research 20050101
Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses. Clinical and experimental immunology 20041001
Effects of the sGC stimulator BAY 41-2272 are not mediated by phosphodiesterase 5 inhibition. Circulation 20040921
Effects of various selective phosphodiesterase inhibitors on carbachol-induced contraction and cyclic nucleotide contents in guinea pig taenia coli. The Journal of veterinary medical science 20040901
PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues. Bioorganic & medicinal chemistry letters 20040607
Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochemical pharmacology 20040515
Nitric oxide inhibits arginine-vasotocin-induced increase of water osmotic permeability in frog urinary bladder. Pflugers Archiv : European journal of physiology 20040501
High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria. Circulation research 20040416
Adenosine deaminase 2 from chicken liver: purification, characterization, and N-terminal amino acid sequence. Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 20040201
Extracellular inosine is modulated by H2O2 and protects sertoli cells against lipoperoxidation and cellular injury. Free radical research 20040101
Phosphoinositide 3-kinase is involved in Xenopus and Labrus melanophore aggregation. Cellular signalling 20031201
Positive inotropic effect of the inhibition of cyclic GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase (PDE2) on guinea pig left atria in eu- and hyperthyroidism. General physiology and biophysics 20031201
Negative functional effects of cyclic GMP are altered by cyclic AMP phosphodiesterases in rabbit cardiac myocytes. European journal of pharmacology 20031114
Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor. British journal of pharmacology 20031101
A simple technique for reducing edge effect in cell-based assays. Journal of biomolecular screening 20031001
Endogenous adenosine modulation of 22Na uptake by rat brain synaptosomes. Neurochemical research 20031001
Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets. Platelets 20030901
An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. The American journal of pathology 20030801
VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors. Thrombosis and haemostasis 20030801
Comparative actions of diazepam and other phosphodiesterase inhibitors on the effects of noradrenaline in rat myocardium. Pharmacology & toxicology 20030701
Tracer adenosine: a novel myocardial flow marker. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20030401
Inhibition of ovarian steroidogenesis by cyclic GMP in a fly. The Journal of endocrinology 20030401
Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors. Bioorganic & medicinal chemistry letters 20030324
Extracellular purines from cells of seminiferous tubules. Molecular and cellular biochemistry 20030301
Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons. Restorative neurology and neuroscience 20030101
Broad spectrum anticonvulsant activity of BW534U87: possible role of an adenosine-dependent mechanism. Pharmacology, biochemistry, and behavior 20021201
Adenosine A(2a) receptor-mediated inhibition of rod opsin mRNA expression in tiger salamander. Journal of neurochemistry 20021101
Effects of an adenosine kinase inhibitor and an adenosine deaminase inhibitor on accumulation of extracellular adenosine by equine articular chondrocytes. American journal of veterinary research 20021101
Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus. The Journal of pharmacology and experimental therapeutics 20020701
Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. American journal of physiology. Heart and circulatory physiology 20020601
Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 20020501
Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases. Thrombosis and haemostasis 20020501
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Does endogenous or exogenous adenosine facilitate the functional recovery of the cochlea after ischemia? The Annals of otology, rhinology, and laryngology 20020401
Phosphodiesterase inhibitors cause relaxation of the internal anal sphincter in vitro. Diseases of the colon and rectum 20020401
Erythro- and threo-2-hydroxynonyl substituted 2-phenyladenines and 2-phenyl-8-azaadenines: ligands for A1 adenosine receptors and adenosine deaminase. Farmaco (Societa chimica italiana : 1989) 20020301
NO-cGMP pathway increases the hyperpolarisation-activated current, I(f), and heart rate during adrenergic stimulation. Cardiovascular research 20011201
A unique ring-expanded acyclic nucleoside analogue that inhibits both adenosine deaminase (ADA) and guanine deaminase (GDA; guanase): synthesis and enzyme inhibition studies of 4,6-diamino-8H-1-hydroxyethoxymethyl-8-iminoimidazo[4,5-e][1,3]diazepine. Bioorganic & medicinal chemistry letters 20011119
Effect of adenosine receptor blockade on pial arteriolar dilation during sciatic nerve stimulation. American journal of physiology. Heart and circulatory physiology 20011101
Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart. Cardiovascular research 20011001
Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply. Circulation 20010918
Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats. Shock (Augusta, Ga.) 20010901
Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase. Pharmaceutical research 20010901
Local response of L-type Ca(2+) current to nitric oxide in frog ventricular myocytes. The Journal of physiology 20010701
Tryptophan environment in adenosine deaminase. I. Enzyme modification with N-bromosuccinimide in the presence of adenosine and EHNA analogues. Biochimica et biophysica acta 20010309
Renal interstitial adenosine metabolism during ischemia in dogs. American journal of physiology. Renal physiology 20010201
NO Inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase. Hypertension (Dallas, Tex. : 1979) 20010201
Regulation of cardiac calcium current by NO and cGMP-modulating agents. Pflugers Archiv : European journal of physiology 20010201
Activation of presynaptic A1-receptors by endogenous adenosine inhibits acetylcholine release in the guinea-pig ileum. Journal of autonomic pharmacology 20010201
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats. Kidney international 19970801
Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram. Cellular signalling 19960201
Evaluation of the effects of erythro-9(2-hydroxy-3-nonyl) adenine (EHNA) on HIV-1 production in vitro. Biochemical and biophysical research communications 19891016
Effects of chirality in 9-(2-hydroxy-3-nonyl)adenine upon deoxyribonucleic acid synthesis in herpes simplex virus-infected cells. Biochemical pharmacology 19831201

© 2019 Angene International Limited. All rights Reserved.